Status:
COMPLETED
Alpha-1-Antitrypsin-Deficiency in COVID-19
Lead Sponsor:
Universität des Saarlandes
Conditions:
Covid19
Eligibility:
All Genders
18-110 years
Brief Summary
The blood concentrations of alpha-1-antitrypsin are monitored during COVID-19. The clinical course of patients that received AAT infusion for clinical indication is monitored.
Detailed Description
The blood concentrations of alpha-1-antitrypsin are monitored during COVID-19. The clinical course of patients that received AAT infusion for clinical indication is monitored. Clinical outcomes, blood...
Eligibility Criteria
Inclusion
- Infection with SARS-COV2
- Age over 18 years
Exclusion
- Unability to consent
- Invasive ventilation
Key Trial Info
Start Date :
April 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04799873
Start Date
April 8 2020
End Date
December 1 2020
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saarland University
Homburg, Saarland, Germany, 66421